Atlantic Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02K Hold
12
– – ﹤0.01% 202
2026
Q1
$2.61K Hold
12
– – ﹤0.01% 216
2025
Q4
$2.74K Sell
12
-16
-57% -$3.65K ﹤0.01% 225
2025
Q3
$6.48K Buy
+28
New +$5.7K ﹤0.01% 187

Other funds holding ABBV

Atlantic Private Wealth's ABBV Position: Q2 2026 in Review

Atlantic Private Wealth held its AbbVie (ABBV) position steady in Q2 2026 at 12 shares worth $3.02K. The position accounts for ﹤0.01% of the portfolio, ranked #202.

Atlantic Private Wealth first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.48K in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Atlantic Private Wealth held 12 shares of AbbVie worth $3.02K as of Q2 2026.
  • Atlantic Private Wealth left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up ﹤0.01% of Atlantic Private Wealth's portfolio in Q2 2026, its #202 holding.
  • Atlantic Private Wealth first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • Atlantic Private Wealth's AbbVie position peaked at $6.48K in Q3 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Atlantic Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.